Article Per Year (5 Year)
p-Index From 2021 - 2026
4.853
P-Index
This Author published in this journals
All Journal HAYATI Journal of Biosciences Jurnal Ilmiah Farmasi Indonesian Journal of Cancer Chemoprevention Majalah Obat Tradisional Jurnal Profesi Medika: Jurnal Kedokteran dan Kesehatan Syntax Literate: Jurnal Ilmiah Indonesia Majalah Farmaseutik Majalah Farmasi dan Farmakologi (Trends in Pharmacy and Pharmaceutical Sciences) Holistik Jurnal Kesehatan Jurnal Farmasi Indonesia JFIOnline Jurnal Ilmu Kefarmasian Indonesia Jurnal Biomedika dan Kesehatan Poltekita : Jurnal Ilmu Kesehatan Majalah Farmasetika To Maega: Jurnal Pengabdian Masyarakat Jurnal Farmamedika (Pharmamedica Journal) SULUH: Jurnal Abdimas Health Information : Jurnal Penelitian Jurnal Kesehatan Poltekkes Kemenkes RI Pangkalpinang Jurnal Kefarmasian AKFARINDO Jurnal Kesehatan Lumbung Farmasi : Jurnal Ilmu Kefarmasian Jurnal Farmagazine Jurnal Buana Farma Binawan Student Journal Journal of Social Research East Asian Journal of Multidisciplinary Research (EAJMR) International Journal of Health and Pharmaceutical (IJHP) Sciences of Pharmacy Jurnal Farmasi Indonesia Kartika : Jurnal Ilmiah Farmasi Jurnal Kefarmasian Indonesia Jurnal Sains dan Kesehatan Journal of Natural Product for Degenerative Diseases Akurasi Jurnal Kesehatan
Dian Ratih Laksmitawati
Universitas Pancasila
Agriculture, Biological Sciences & Forestry Humanities Biochemistry, Genetics & Molecular Biology Chemical Engineering, Chemistry & Bioengineering Chemistry Computer Science & IT Decision Sciences, Operations Research & Management Dentistry Earth & Planetary Sciences Economics, Econometrics & Finance Education Environmental Science Health Professions Immunology & microbiology Industrial & Manufacturing Engineering Law, Crime, Criminology & Criminal Justice Library & Information Science Materials Science & Nanotechnology Medicine & Pharmacology Nursing Public Health Social Sciences Other

Published : 58 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search
Journal : Jurnal Kesehatan

 1 
ANALISIS KLAIM PEMBIAYAAN KEMENKES DAN BIAYA RIIL RS PADA COVID-19 DI RSUD CEMPAKA PUTIH JAKARTA Ana Yupita Liza; Dian Ratih Laksmitawati; Prih Sarnianto; Selvy Devita Anggeraini
Jurnal Kesehatan Vol. 13 No. 2 (2022)
Publisher : Sekolah Tinggi Ilmu Kesehatan (STIKes) Cirebon

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.38165/jk.v13i2.323

Abstract

Coronavirus Disease 2019 (COVID-19) merupakan penyakit menular yang disebabkan oleh Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Kasus COVID-19 diperparah oleh beragam komorbid, menyebabkan biaya per pasien menjadi bervariasi. Pemerintah mengalokasikan dana yang tinggi sebagai strategi dalam upaya percepatan penanggulangan wabah COVID-19 yang teknis pengajuan klaimnya merujuk pada Keputusan Menteri Kesehatan 446/2020 dan 4344/2021. Penelitian ini bertujuan untuk mengetahui selisih biaya yang diterima oleh rumah sakit dari Kementerian Kesehatan (Kemenkes) dengan biaya riil rumah sakit. Pada penelitian observasional ini, sampel (236 responden) diambil secara acak dari populasi pasien rawat inap COVID-19 derajat sedang periode Januari–Juni 2021 (597 pasien) menggunakan tabel Krejcie dan Morgan. Data restrospektif diambil dari rekam medis, casemix, dan penagihan (billing), secara potong-lintang. Hasil analisis deskriptif yang dilakukan menunjukkan bahwa pasien COVID-19 dalam penelitian ini sebagian besar adalah perempuan (139 orang, 58,9%), rentang usia 18–82 tahun dan sebagian besar dari kelompok usia 26–45 tahun (102 orang, 43,2%), tidak memiliki komorbiditas (121 orang, 51,3%), dengan rerata lama rawat-inap (LoS) 10 hari. Terkait biaya, total realisasi klaim pembiayaan periode Januari–Juni 2021 yang diterima dari Kemenkes mencapai Rp18.659.815, atau lebih tinggi secara signifikan dibanding total biaya riil rumah sakit (Mann-Whitney, p <0,05). Dari biaya riil rumah sakit Rp2.286.282.430, komponen terbesar adalah obat Rp557.193.006 (24,37%). Rerata selisih antara klaim dan biaya riil yang cukup tinggi, Rp57.860.630 -Rp76.870.587 per pasien tersebut belum memperhitungkan biaya investasi yang dikeluarkan rumah sakit dalam bentuk berbagai peralatan (seperti ventilator) dan fasilitas lainnya (ruang isolasi bertekanan negatif, penambahan ruangan ICU dan HCU) yang belum tentu produktif setelah pandemi berlalu, sehingga dapat dikatakan wajar. Selisih positif tersebut menurun setelah diberlakukannya Keputusan Menteri Kesehatan Nomer 4344/2021 untuk periode 20 April 2021 sampai 30 Juni 2021 sebagai bentuk evaluasi secara berkesinambungan dari pemerintah terhadap pembiayaan COVID-19.Kata Kunci: COVID-19; analisis biaya; realisasi klaim; biaya riil; selisih biaya AbstractCoronavirus Disease 2019 (COVID-19) is an infectious disease caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Cases of COVID-19 are exacerbated by various comorbidities which lead to various per patient costs. The government allocates high funds as a strategy to accelerate the management of the COVID-19 outbreak, wherein the technical claims refer to the Decree of the Minister of Health number 446/2020 and 4344/2021. This study aims to determine the difference between costs received by hospitals from the Ministry of Health and the real costs incurred by the hospitals. This was an observational study which involved 236 respondents who were randomly selected from the population of moderate-degree COVID-19 inpatients for the period January–June 2021 (597 patients) by using Krejcie and Morgan table. Retrospective data were taken from medical records, casemix, and billing, cross-sectionally. The results of the descriptive analysis conducted showed that most of COVID-19 patients in this study were women (139 respondents or 58.9%). Age of respondents ranged from 18–82 years old and most of respondents were involved in the age group of 26–45 years (102 respondents or 43, 2%). Furthermore, most of respondents had no comorbidities (121 respondents or 51.3%), with the mean length of stay (LoS) of 10 days. Regarding costs, the total realization of financing claims for the period January–June 2021 from the Ministry of Health was IDR 18,659,815, or significantly higher than the total real hospital costs (Mann-Whitney, p < 0.05). Of the real hospital costs of IDR 2,286,282,430, the largest component was medicine by IDR 57,193,006 (24.37%). The mean difference between claims and real costs was quite high by IDR 57,860,630 – IDR 76,870,587 per patient, by not considering the investment costs incurred by the hospital in the form of various equipment (such as ventilators) and other facilities (negative pressure isolation rooms, as well as additional ICU and HCU wards) which are not necessarily productive after the pandemic has passed. Thus, it can be said that such difference was natural. The positive difference decreased after the enactment of Decree of the Minister of Health No. 4344/2021 for the period April 20, 2021 to June 30, 2021 as a form of continuous evaluation provided by the government towards COVID-19 financing.Keywords: COVID-19; cost analysis; claim realization; real cost; difference in cost
Co-Authors . Syamsudin Ahmad Faried Ana Yupita Liza Andayani, Nurita Andreas Infianto Ani Retno Prijanti Annisa Septyana Putri Ayu Werawati Bagus Bahtiar Bambang Ponco Priosoeryanto Cahyaning Riski Wijayanti Caroline Tan Sardjono CAROLINE TAN SARDJONO Chandra, Pra Panca Bayu Claudia Tiffani Dedy Kurniawan Deni Rahmat Deni Rahmat Devina Harti Syaputri Diah Kartika Pratami Diar Gustianti Istita Edwin Tomasoa Effionora Anwar Effionora Anwar Elisabeth Ninung Yuliarti Esti Mumpuni Esti Mumpuni Esti Mumpuni Esti Mumpuni, Esti Faradiba Faradiba Faridah Faridah Ferry Sandra Hanna Sari W Kusuma Hanna Sari Widya Kusuma HARI PURNOMO Hendig Winarno Hendig Winarno Hesti Utami Ramadaniati Hesti Utami Ramadaniati Hikariastri, Pangartika Indah Zahara Ivans Panduwiguna James Ibrahim Jayati, Turpuk Mannaria Jeanette Mangiwa Jeanne A. Pawitan Jeanne Adiwinata Pawitan Juliana Irem Adriana Purukan Katharina Aditya Candra Utukaman Kusmardi Kusmardi Kusmardi Kusmardi Laili Savitri Noor Laksono Trisnantoro Larasinta, Nadia Lia Warti Liliek Nurhidayati Magdalena Niken Oktovina Marwati, Umi Marybet Tri Retno Handayani Meilda Ayu Bathini Mita Restina Moch Futuchul Arifin Mohamad Sadikin Mohammad Sadikin Mokhamad mahroji Muhammad Hanafi Mulatsari, Esti Noor, Laili Savitri Novia Maulina Novia Maulina Nuraini Nuraini Nurita Andayani Okta, Fauzia Noprima Oriza Safrini Oriza Safrini Panca, Pra Panca Bayu Chandra Pangartika Hikariastri Partana, Citra Prastuti Partomuan Simanjuntak Patminingsih, Nanik Pra Panca Bayu Chandra Pra Panca Bayu Chandra Prasasta Sutedjo Prih Sarnianto Prih Sarnianto Prih Sarnianto Prilasari, Sharon Alia Rachmawati Noverina RAHMAT, DENI Rahmawati, Siti Irma Ramadaniati, Hesty Utami Ranald Irwanto Ratih Rinendyaputri Renni Septini Rikkit Sihombing Rilianawati Rilianawati Riska Eka Putri, Riska Eka Rizal Rizal Rizal Rizal Ronald Irwanto Ronald Irwanto Natadidjaja ROS SUMARNY Ros Sumarny Ros Sumarny Rudi Asmajaya Sahat Saragi Sampurno Sampurno Sampurno Sampurno Sarwono Waspadji Seila Arumwardana Selvy Devita Anggeraini Shelly Taurhesia Simbolon, Roslan Simbolon, Roslan Siti Umroh Noor Sutarno Syamsudin Abdillah Teulis Sumiartini Tomasoa, Edwin Trisna Lestari Umi Marwati Utukaman, Katharina Aditya Candra Vergie Indriani Wahono Sumaryono Wahyu Widowati Wahyu Widowati Wireni Ayuningtyas Yoppy Mayrosa Yudha Sukowati Yusi Anggraini Yusi Anggriani Yusi Anggriani Zahara, Indah